Non-immunosuppressive treatment for IgA nephropathy.

An updated Cochrane systematic review found that among non-immunosuppressive treatments for IgA nephropathy, renin-angiotensin system inhibition is the most beneficial, reducing proteinuria with a favorable balance of benefits over harms, while evidence for other non-immunosuppressive therapies remains weak.